Not an SEC registrant

Spark Therapeutics INC.

Customers

2 federal agencies

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$419.0M

FY2024 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 2

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $419.0M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$397.2M	FY 2024	4	$2.3M → $397.2M	75A50324F80002
EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING TAMIFLU 75MG CAPSULES (NDC 0004-0800-85) AND TAMIFLU 30MG CAPSULES (NDC 0004-0802-85) Award 75A50324F80002 on USAspending.gov ↗ Largest of 4 awards in FY2024: $397.0M obligated
Department of Veterans Affairs Department of Veterans Affairs	$21.7M	FY 2024	9	$19.2M → $21.7M	36C10G24N0009
GENOMIC SEQUENCING TESTING SERVICES Award 36C10G24N0009 on USAspending.gov ↗ Largest of 9 awards in FY2024: $23.0M obligated

Alerts are coming

Get an email when Spark Therapeutics INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.